Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

NorwayBack to Norway

Clinical trials in Trondheim – page 4

195 clinical trials in Trondheim, Norway across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Trondheim at a glance
195
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

195 trials in Trondheim

Open in trial search

Acute myeloid leukaemia

Recruiting

Study on Ivosidenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Chronic lymphocytic leukaemia+1

Recruiting

Study on Venetoclax, Obinutuzumab, and Pirtobrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:University Of Cologne

Ischaemic stroke

Recruiting

Study on the Effectiveness of Tenecteplase in Patients with Acute Ischemic Stroke Taking Rivaroxaban, Apixaban, or Edoxaban

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Alteplase
  • Sponsor:Oslo University Hospital HF

Acute myeloid leukaemia

Recruiting

Study on Revumenib, Azacitidine, and Venetoclax for Adults with Newly Diagnosed Acute Myeloid Leukemia Not Eligible for Intensive Chemotherapy

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Testicular seminoma (pure) stage I

Recruiting

Study Comparing Chemotherapy Options for Patients with Stage I Testicular Cancer: Bleomycin, Etoposide, Cisplatin vs. Carboplatin

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Bleomycin
  • Sponsor:St. Olavs Hospital HF

Hepatocellular carcinoma+1

Recruiting

Study of drug combinations including cisplatin, carboplatin, doxorubicin, fluorouracil, vincristine, etoposide, irinotecan, gemcitabine, oxaliplatin and sorafenib for children with hepatoblastoma or hepatocellular carcinoma

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years
  • Substances:Carboplatin
  • Sponsor:The University Of Birmingham

Follicular lymphoma

Recruiting

Study on Rituximab, Lenalidomide, and Tafasitamab for Treating High-Risk and Low-Risk Follicular Lymphoma Patients

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Karolinska University Hospital

Wheezing+1

Recruiting

Study on Betamethasone Sodium Phosphate to Prevent Asthma in Children with First-time Rhinovirus-induced Wheezing

Registered drug
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Betamethasone Sodium Phosphate
  • Sponsor:St. Olavs Hospital HF

Colorectal cancer metastatic

Recruiting

Study comparing oxaliplatin and irinotecan chemotherapy effectiveness using tumor testing in patients with metastatic colorectal cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Oxaliplatin
  • Sponsor:St. Olavs Hospital HF

Neoplasm malignant

Recruiting

Study on Dabrafenib, Trametinib, and Imatinib for Patients with Rare and Hard-to-Treat Cancers

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Dabrafenib
  • Sponsor:Oslo University Hospital HF

Back pain

Recruiting

Study on Zoledronic Acid for Patients with Chronic Low Back Pain with Modic Changes

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Sodium Chloride
  • Sponsor:Oslo University Hospital HF

Extra-osseous Ewing's sarcoma+5

Recruiting

Study of drug combination therapy for patients with recurrent and primary refractory Ewing Sarcoma

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Anhydrous Docetaxel
  • Sponsor:The University Of Birmingham

Other cities in Norway

The busiest research cities in the country

All 54 cities in Norway

Clinical research in Trondheim

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials investigating treatments for various cancer types, including pancreatic ductal cancer, gastric cancer, and follicular lymphoma. Studies focus on evaluating new therapeutic combinations and precision medicine approaches.

  • Targeted therapies for HER2-positive cancers
  • Pediatric liver tumors
  • Breast cancer personalized treatment

Multiple trials are exploring immunotherapy combinations and novel drug applications for improved patient outcomes.

02 Neurological Disorders

Research focusing on innovative treatments for Alzheimer's disease and brain tumors. Studies include evaluation of new drug combinations and comparative effectiveness of existing therapies.

  • Early-stage Alzheimer's interventions
  • Glioblastoma treatment strategies
  • Meningioma therapeutic approaches

Trials aim to improve patient outcomes through targeted therapeutic interventions and biomarker studies.

03 Respiratory and Infectious Diseases

Studies examining treatments for chronic wet cough in children and respiratory infections. Research includes antibiotic efficacy trials and innovative treatment approaches.

  • Pediatric respiratory infections
  • Antibiotic effectiveness studies
  • Wheezing prevention in children

Focus on developing evidence-based treatment protocols for respiratory conditions in pediatric populations.

Back to NorwayAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.